MELINTA THERAPEUTICS, INC. /NEW/ Inventory Write-down
MELINTA THERAPEUTICS, INC. /NEW/ reported Inventory Write-down of $394.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2019-11-12
- MELINTA THERAPEUTICS, INC. /NEW/ inventory write-down for the quarter ending 2019-09-30 was $2.00K, a 99.95% decline year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ inventory write-down for the quarter ending 2018-12-31 was $986.00K.
- MELINTA THERAPEUTICS, INC. /NEW/ inventory write-down for the quarter ending 2018-09-30 was $4.00M.
- MELINTA THERAPEUTICS, INC. /NEW/ inventory write-down for the quarter ending 2017-12-31 was $0.00.
- MELINTA THERAPEUTICS, INC. /NEW/ inventory write-down for fiscal 2018 was $8.04M.
- MELINTA THERAPEUTICS, INC. /NEW/ inventory write-down for fiscal 2017 was $0.00.
- MELINTA THERAPEUTICS, INC. /NEW/ inventory write-down for fiscal 2016 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2019-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $394.00K 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | $392.00K 10-Q · filed 2019-08-09 | |||
| 2018-12-31 | $986.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $4.98M derived: sum of 2 quarters · filed 2019-03-14 | $8.04M 10-K · filed 2019-03-14 | |
| 2018-09-30 | $4.00M 10-Q · filed 2018-11-07 | $7.06M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $2.53M 10-Q · filed 2019-08-09 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $0.00 10-K · filed 2019-03-14 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-14 |